FindTrial
Sign In

Clinical features and treatment outcomes among children with Stevens-Johnson syndrome and toxic epidermal necrolysis: a 20-year study in a tertiary referral hospital

Clinical features and treatment outcomes among children with Stevens-Johnson syndrome and toxic epidermal necrolysis: a 20-year study in a tertiary referral hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20180109004
Enrollment
Unknown
Registered
2018-01-09
Start date
2017-01-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

clinical features&#44

Interventions

SJS is defined as the area of epidermal detachment 10% of the body surface area (BSA)
Diagnostic,Diagnostic
SJS group,Overlap&#45
TEN group

Sponsors

no
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: The database for all inpatient paediatric patients (<18 years old) diagnosed with SJS&#44; TEN or SJS&#45;TEN overlap by paediatric dermatologists and admitted to the King Chulalongkorn Memorial Hospital&#44; Bangkok&#44; Thailand&#44; from January 1997 and December 2016 was retrospectively reviewed

Exclusion criteria

Exclusion criteria: uncertain diagnosis

Design outcomes

Primary

MeasureTime frame
clinical features 10 months clinical outcomes—

Secondary

MeasureTime frame
complication 10 months chart review—

Countries

Thailand

Contacts

Public ContactSusheera Chatproedprai

Department of Pediatric&#44; Faculty of Medicine&#44; Chulalongkorn University

susheera.c@chula.ac.th6622564951

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026